Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(5), 1850-1855.